sb 202190 has been researched along with Angiitis in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shan, Y | 1 |
| Zhao, R | 1 |
| Geng, W | 1 |
| Lin, N | 1 |
| Wang, X | 1 |
| Du, X | 1 |
| Wang, S | 1 |
1 other study available for sb 202190 and Angiitis
| Article | Year |
|---|---|
Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage.
Topics: Anisomycin; Anthracenes; Anticarcinogenic Agents; Blotting, Western; Cell Line; Cyclooxygenase 2; Dr | 2010 |